FDA Approves Two New Melanoma Rx
Melanoma, the most dangerous form of skin cancer, now has two new enemies. The FDA has approved two drugs to treat melanoma that has spread to other organs (metastatic) or can’t be surgically removed.
FDA Approves Two Drugs, Companion Diagnostic Test for Advanced Skin Cancer
The US Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.
FDA Issues Proposal to Increase Consumer Awareness of Tanning Bed Risks
Today, the US Food and Drug Administration issued a proposed order that, if finalized, would reclassify sunlamp products and require labeling to include a recommendation designed to warn young people not to use these devices.
Trametinib US PDUFA Date Extended to September 2013
GSK today announced that the US Prescription Drug User Fee Act (PDUFA) goal date for trametinib, its MEK inhibitor, has been extended by 3 months to 3 September 2013.
Skin Cancer Survivors Not Practicing Safe Sun
Sunny days are among life’s finest pleasures. Being outdoors when the sun shines bright requires some protection, though. And you’d think people who’ve had skin cancer would know these things and practice safe sun all the time.
Skin Cancer Protection with Aspirin
Aspirin has been making headlines as a way to reduce the risk for heart trouble and maybe even certain forms of cancer. But aspirin’s side effects may outweigh the benefits.
FDA Approves Lymphoseek to Help Locate Lymph Nodes
The US Food and Drug Administration today approved Lymphoseek (technetium Tc 99m tilmanocept) Injection, a radioactive diagnostic imaging agent that helps doctors locate lymph nodes in patients with breast cancer or melanoma who are undergoing surgery to remove tumor-draining lymph nodes.
Hey Guys, Check Your Skin
Men aged 50 years and older haven’t been checking themselves for signs of skin cancer, according to recent studies. Early detection of skin cancer is essential for nipping it in the bud.
Melanoma Clinical Trials Worth a Shot
Treating melanoma is notoriously tricky. Doctors may hesitate to recommend clinical trials fearing the risks for patients outweigh the rewards. But these fears may be unfounded.
Hey Doc, Is This a Side Effect?
There’s no need to suffer in silence. Side effects of melanoma medications can be managed, but only if the patient tells the doctor about all of the symptoms as soon as they appear.